We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Interrelations Between Spontaneous Otoacoustic Emissions and Transient Evoked Emissions

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01325272
First Posted: March 29, 2011
Last Update Posted: June 1, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
UPECLIN HC FM Botucatu Unesp
  Purpose
To verify the occurrence of Spontaneous Otoacoustic Emissions (SOAE) in neonates at term and preterm infants who had transient otoacoustic emissions and verify if the presence of response is related to gestational age, gender or risk factors for hearing loss.

Condition
Cochlear Function

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Interrelations Between Spontaneous Otoacoustic Emissions and Transient Evoked Emissions: Indication of Cochlear Damage in Newborn.

Further study details as provided by UPECLIN HC FM Botucatu Unesp:

Study Start Date: March 2009
Estimated Study Completion Date: September 2009
Groups/Cohorts
preterm newborn
term newborn

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 5 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Children born in this institution
Criteria

Inclusion Criteria:

  • born in this institution
  • have presence of transient otoacoustic emission

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01325272


Locations
Brazil
Faculdade de Medicina de Botucatu
Botucatu, SP, Brazil, 18603970
Sponsors and Collaborators
UPECLIN HC FM Botucatu Unesp
Investigators
Principal Investigator: Daniela Polo Camargo da Silva, Mestre Faculdade de Medicina de Botucatu
  More Information

Responsible Party: Daniela Polo Camargo da Silva, Faculdade de Medicina de Botucatu
ClinicalTrials.gov Identifier: NCT01325272     History of Changes
Other Study ID Numbers: upeclin/HC/FMB-Unesp-53
First Submitted: March 28, 2011
First Posted: March 29, 2011
Last Update Posted: June 1, 2011
Last Verified: May 2011

Keywords provided by UPECLIN HC FM Botucatu Unesp:
otoacoustic emissions in newborns